HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING—
Price Investing Group
← Back to Research Watchlist
PVLA
Palvella Therapeutics Inc
Healthcare Biotechnology · Pennsylvania, USA · Reports in usd
—
Market Cap: $1.93B
Market Cap
$1.93B
Enterprise Val
$1.68B
P/E Ratio
-31.24
P/B Ratio
8.89
Trailing PEG (1Y)
-0.41
As Of
Oct 11, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$216.9M
Return on Equity-47.84%
Return on Assets-38.33%
Current Ratio21.18
Debt/Equity0.00
LT Debt/Equity0.00
Revenue Per Share0.00

Income Statement

Jun 30, 2026
Revenue$0.00
Cost of Revenue$0.00
Gross Profit$0.00
R&D$12.5M
SG&A$8.9M
Operating Expenses$21.4M
Operating Income-$21.4M
Interest Expense$2.3M
Tax Expense$0.00
Net Income-$21.9M
EPS (Basic)$-1.52
EPS (Diluted)$-1.52
EBIT-$19.6M
EBITDA-$19.5M
Consolidated Income-$21.9M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$187.8M
Accounts Receivable$0.00
Inventory$0.00
Current Assets$253.0M
LT Investments$0.00
Property, Plant & Equipment$482.0K
Intangibles$0.00
Non-Current Assets$482.0K
Total Assets$253.5M
Accounts Payable$6.8M
Current Debt$217.0K
Current Liabilities$11.9M
LT Debt$318.0K
Non-Current Liabilities$24.7M
Total Liabilities$36.6M
Total Debt$535.0K
Retained Earnings-$173.1M
Shareholder Equity$216.9M
Shares Outstanding14,342,844

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow-$12.8M
Investing Cash Flow-$7.0M
Financing Cash Flow$1.3M
CapEx$0.00
Free Cash Flow-$12.8M
Depreciation & Amort.$45.0K
Stock-Based Comp$5.2M
Acquisitions / Disposals$0.00
Investment Activity-$7.0M
Debt Issued/Repaid$0.00
Equity Issued/Repaid$1.3M
Dividends Paid$0.00
Net Change in Cash-$18.6M
Data cached · Meta live · Daily live · Statements live · TTL 24h